Source: https://www.ecfr.gov/cgi-bin/text-idx?mc=true&node=se21.6.522_11260&rgn=div8
Timestamp: 2020-07-10 00:00:17
Document Index: 66859625

Matched Legal Cases: ['art 522', '§522', '§522', '§510', '§201', '§556']

Title 21 → Chapter I → Subchapter E → Part 522 → §522.1260
§522.1260 Lincomycin.
(b) Sponsors. See sponsors in §510.600(c) of this chapter for uses as in paragraph (e) of this section.
(4) No. 061133 for use of concentrations in paragraph (a)(4) of this section as in paragraph (e)(2) of this section.
(c) Special considerations. When common labeling for use of the drug in dogs, cats, and swine is included with the drug, all such uses are subject to the labeling requirements of §201.105 of this chapter.
(d) Related tolerances. See §556.360 of this chapter.
(1) Dogs and cats—(i) Amount. 5 mg per pound (/lb) of body weight twice daily or 10 mg/lb body weight once daily by intramuscular injection; 5 to 10 mg/lb body weight one or two times daily by slow intravenous injection.
(2) Swine—(i) Amount. 5 mg/lb body weight once daily by intramuscular injection for 3 to 7 days.
[40 FR 13858, Mar. 27, 1975, as amended at 50 FR 31351, Aug. 2, 1985; 67 FR 34388, May 14, 2002; 68 FR 51705, Aug. 28, 2003; 69 FR 11507, Mar. 11, 2004; 69 FR 47361, Aug. 5, 2004; 71 FR 51996, Sept. 1, 2006; 78 FR 17597, Mar. 22, 2013; 79 FR 16191, Mar. 25, 2014; 81 FR 59134, Aug. 29, 2016; 84 FR 8974, Mar. 13, 2019]